Skip to content

Rachel S. Kelly, PhD

Research Areas: Metabolomics; Metabolomic Epidemiology; Integrative-Omics; Neurodevelopment; Autism Spectrum Disorder; Respiratory Disease

Dr. Rachel Kelly serves as an Assistant Professor of Medicine in the Channing Division of Network Medicine at Brigham and Women’s Hospital and Harvard Medical School. Her primary focus is translational research, centered on metabolomic epidemiology and integrative -omics. She holds a specific interest in understanding the impact of early life exposures on later-life disease risk mechanisms, particularly in common complex diseases. Dr Kelly has over 130 publications and plays leading roles in the metabolomics and omics communities, including as Chair of the American Thoracic Society Section on Genetics and Genomics, Vice Chair of the International COnsortium of METabolics Studies (COMETS) and co lead of the STROBE Metabolomic epidemiology Initiative.

hprke@channing.harvard.edu

Connect with us.